You are currently browsing the archives for the day: Tuesday, den 22. April 2008.

April 22, 2008

Pulse Oximeters Market To Exceed 438 Million Dollars By 2010, According To New Report By Global Industry Analysts, Inc.

With healthcare facility consolidation and increasing standardization, the market for pulse oximeters seems to be favorably poised. Product innovations, path-breaking technologies, advanced sensors are the principal driving factors for the pulse oximeters market. The technology has emerged as a widely accepted method of measuring arterial oxygen saturation in hospitals, subacute care centers, EMS and home settings.

Comments Comments | Categories: Heart | Autor: smart




Medipattern’s B-CAD(TM) Approved For Sale In China

The Medipattern Corporation (TSX VENTURE:MKI), an award-winning developer of computer-aided detection (CAD) medical imaging software designed to aid physicians in making better informed biopsy decisions and to permit a higher standard of care for the millions of patients at risk of cancer, is pleased to announce receipt of State Food and Drug Administration (SFDA) approval in the People’s Republic of China for its B-CAD(TM) product.

Comments Comments | Categories: Cancer | Autor: smart




Pollen Season and the Oral Allergy Syndrome

During the height of pollen season, people with seasonal allergies may notice that they begin to experience allergic reactions to fresh fruits and vegetables. These reactions, called the oral allergy…

Comments Comments | Categories: Allergies | Autor: smart




AdvaMed Responds To Proposed FY 2009 Inpatient Hospital Payment Rule

Ann-Marie Lynch, executive vice president for payment and health care delivery policy at the Advanced Medical Technology Association (AdvaMed), released the following statement regarding the Centers for Medicare and Medicaid Services’ (CMS) proposed FY 2009 inpatient hospital payment rule: “We are pleased that in FY 2009 CMS will complete the two-year phase-in of the MS-DRG patient classification system.

Comments Comments | Categories: Medications | Autor: smart




Everolimus-releasing Stent Promising For Coronary Artery Disease Patients

A recent study published in JAMA found thatdrug-releasing stents improve outcomes for patients with coronaryartery disease who received angioplasty to open narrowed arteries.Gregg W. Stone, M.D.

Comments Comments | Categories: Heart | Autor: smart




CQ’s Armstrong Discusses Medicaid Legislation, Senate Hearing On FDA Funding, GAO Report On Hospital-Acquired Infections

Drew Armstrong, a health reporter for CQ, examines bipartisan Medicaid legislation cleared for House floor action, a Senate hearing about FDA funding and a Government Accountability Office report examining hospital-acquired infections in this week’s “Health on the Hill from kaisernetwork.

Comments Comments | Categories: Medications | Autor: smart




HHS Appeals Decision That Requires Release Of Medicare Physician Claims Data

HHS last week in the U.S. Court of Appeals for the District of Columbia filed an appeal of an August 2007 court decision that requires the department to release Medicare claims data on more than 40 million beneficiaries and 700,000 physicians, the

Comments Comments | Categories: Medications | Autor: smart




Bush Administration Directive To Enroll Low-Income Children In SCHIP Before Expanding Coverage Is Unenforceable Because It Violates Federal Law

The Bush administration violated federal law last year when it issued a policy directive that restricts states’ ability to expand their SCHIP programs, according to a Government Accountability Office legal opinion released Friday, the

Comments Comments | Categories: Medications | Autor: smart




Fla. Senate Rejects Proposal To Add Comprehensive Sex Education Amendment To Evolution Bill

The Florida Senate on Thursday rejected a proposal to add a comprehensive sex education amendment to an education bill (

Comments Comments | Categories: Women's Health | Autor: smart




New York Times Examines Increasing Prices Of Specialty Drugs Distributed Exclusively By Pharmacy Benefit Managers

The New York Times on Saturday examined how pharmacy benefit managers in recent years “have built lucrative side businesses … acting as exclusive or semi-exclusive distributors of expensive specialty drugs.

Comments Comments | Categories: Medications | Autor: smart